Interpublic Increases Common Stock Dividend by 12%
New York, Feb. 13, 2019 (GLOBE NEWSWIRE) — Interpublic Group (NYSE: IPG) today announced that the company’s Board of Directors […]
New York, Feb. 13, 2019 (GLOBE NEWSWIRE) — Interpublic Group (NYSE: IPG) today announced that the company’s Board of Directors […]
All amounts expressed in U.S. dollars unless otherwise indicated TORONTO, Feb. 13, 2019 (GLOBE NEWSWIRE) — Barely six weeks after […]
New York, Feb. 13, 2019 (GLOBE NEWSWIRE) — Q4 2018 net revenue grew 13.3% to $2.41 billion, with strong organic […]
VANCOUVER, British Columbia, Feb. 13, 2019 (GLOBE NEWSWIRE) — Nash Pharmaceuticals Inc., a wholly owned subsidiary of Breathtec Biomedical Inc. (CSE: BTH) […]
Summit Therapeutics plc (‘Summit’ or the ’Company’) Summit Doses First Patient in Phase 3 Clinical Trials of Precision Antibiotic Ridinilazole […]
– Record Revenues for the Fourth Quarter and Full Year –– Establishes 2019 First Quarter and Full Year Guidance – […]
Issuance of new patents strengthens the intellectual property around Melt Pharmaceuticals’ flagship drug candidate and potential label extensions SAN DIEGO […]
YONKERS, N.Y., Feb. 13, 2019 (GLOBE NEWSWIRE) — ContraFect Corporation (Nasdaq:CFRX), a clinical-stage biotechnology company focused on the discovery and […]
Reports record fourth quarter revenue of $141.0 million Reports fourth quarter GAAP loss per share of $0.35 and non-GAAP earnings […]
NICOSIA, Cyprus, Feb. 13, 2019 (GLOBE NEWSWIRE) — QIWI plc (NASDAQ: QIWI) (MOEX: QIWI) (“QIWI” or the “Company”), a leading […]